We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
31 hedge funds and large institutions have $12.8M invested in Madrigal Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 21 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
35% more capital invested
Capital invested by funds: $9.44M → $12.8M (+$3.33M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
44% less funds holding
Funds holding: 55 → 31 (-24)
59% less call options, than puts
Call options by funds: $26K | Put options by funds: $63K
76% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 21
88% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 26
Holders
31
Holders Change
-24
Holders Change %
-43.64%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
5
Reduced
21
Closed
26
Calls
$26K
Puts
$63K
Net Calls
-$37K
Net Calls Change
-$55K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$1.11M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$610K |
| 3 |
Goldman Sachs
New York
|
+$43.3K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$31.8K |
| 5 |
JP Morgan Chase
New York
|
+$853 |
